Gainers
- Spero Therapeutics, Inc. (NASDAQ:SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
- HeartBeam, Inc. (NASDAQ:BEAT) shares rose 27.8% to $2.02 in pre-market trading after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
- American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 20.1% to $0.2590 in pre-market trading.
- Taoping Inc. (NASDAQ:TAOP) rose 19.7% to $0.73 in pre-market trading. Taoping recently posted 1H revenue of $10.5 million.
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) rose 18.4% to $0.3672 in pre-market trading after declining around 7% on Wednesday.
- Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) rose 15.8% to $1.90 in pre-market trading after dropping over 5% on Wednesday.
- Organovo Holdings, Inc. (NASDAQ:ONVO) rose 15.3% to $2.45 in pre-market trading.
- Ensysce Biosciences, Inc. (NASDAQ:ENSC) rose 12% to $0.2660 in pre-market trading after declining 5% on Wednesday.
- Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) rose 11.2% to $1.98 in pre-market trading after declining over 4% on Wednesday.
- Timber Pharmaceuticals, Inc. (NYSE:TMBR) rose 10.3% to $0.1138 in pre-market trading. Timber Pharmaceuticals recently received positive opinion on Orphan Designation from European Medicines Agency For TMB-001.
- SmartRent, Inc. (NYSE:SMRT) rose 8.1% to $2.93 in pre-market trading after gaining around 7% on Wednesday.
- Deutsche Bank Aktiengesellschaft (NYSE:DB) rose 6.3% to $9.14 in pre-market trading. Deutsche Bank said its New York Branch, Deutsche Bank New York, and its affiliate Deutsche Bank Trust Company Americas have raised their prime lending from 5.50% to 6.25%.
